Optimizing Outcomes and Access to Medication Agonist Treatment Using Buprenorphine/Naloxone by Innovative Precision Medicine

1. Novel Clinical Protocol and Evidence of Effectiveness – Hesham Farouk Elarabi (UAE), Shamil David Wanigaratne (UK)
2. Predictors of Illicit Opioid Use and Retention in Treatment – Hamad Al Ghafri, Hesham Elarabi (UAE)
3. Critical Analysis of Prescribing Psychotropics in Co-occurring Disorders and Polysubstance Use – Hesham Elarabi, Mansour Assaf (UAE)
4. Estimation of disease burden and cost-effectiveness and harm reduction in polysubstance use – Hesham Elarabi, Hamad Al Ghafri (UAE)
5. Novel Clinical Algorithm for management of opioid use disorder and innovative point of care device applications – Hesham Elarabi, Mansour Assaf (UAE)